The FDA specifically stated that our preliminary evaluation has not found evidence that use of these medicines causes suicidal thoughts or actions while the MHRA noted that the available evidence does not establish a causal relationship between GLP-1 receptor agonists and suicidal behavior, suicidal ideation, self-injury and depression. Taken together, these formal investigations did not reveal evidence of a causal relationship between the use of GLP-1s and suicidal thoughts, self-injurious behavior, or even depression
As of early 2026, 503A compounding pharmacies may compound semaglutide under specific conditions related to drug shortage status and patient-specific prescriptions
How to Take Boots Glutathione Complex Safely
Side effects from a recent step up are still settling
Our attorneys have extensive experience representing people injured car, auto, and motor vehicle accidents, motorcycle crashes, truck accidents, drunk driving accidents, cruise ship accidents, maritime accidents, slip and falls, medical malpractice, premises liability, and violent crime cases